Nuvectis Pharma, Inc. , a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology.
Nuvectis Pharma stock last closed at $8.23, up 1.86% from the previous day, and has decreased 11.98% in one year. It has overperformed other stocks in the Biotechnology industry by 0.35 percentage points. Nuvectis Pharma stock is currently +48.29% from its 52-week low of $5.55, and -28.56% from its 52-week high of $11.52.
There are currently 26.49M shares of NVCT outstanding. The market cap of NVCT is $218.03M. In the past 24 hours, 98,000 NVCT shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy NVCT stock.
We believe that eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal info so you can invest in NVCT today.
Now that you have opened your account on investing apps, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help depositing money into your investment account.
Once you have chosen the best place to buy Nuvectis Pharma stock, it's very important to research their stock prior to buying, so you actually comprehend the risk and upside.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on NVCT's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge NVCT's intrinsic value.
Using relative valuations ratios:
You can access more valuation analysis on NVCT's stock here.
You can dive deeper into what analysts are projecting on the Nuvectis Pharma stock forecast page.
In the past 12 months, insiders at NVCT have bought more shares than they have sold.
Ron Bentsur, Chairman CEO of NVCT, was the latest NVCT insider to buy. They bought $28,600.00 worth of NVCT shares on Nov 5, 2025.
Dig into more about who owns NVCT shares here.
No, Nuvectis Pharma doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary order types:
Click the Open button and your broker will execute the order.
If you require additional help with investing in stocks on eToro, click the helpful video below:
Now that you own some shares in NVCT, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to get alerted to the latest events about your NVCT stock.
To summarize, here are the 6 steps you need to take to buy Nuvectis Pharma stock right now:
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Nuvectis Pharma, create a watchlist today.